Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03284034 · ClinicalTrials.gov registry record · NA
Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03284034: Clinical Trial NA study, sponsored by Northwestern University.
NCT03284034 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03284034, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a prospective randomized controlled study comparing the efficacy of cryolipolysis versus ATX-101 (deoxycholic acid) for the treatment of upper back fat. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. The treatment sites are the right and left upper back fat areas. The right and left sides of the upper back fat will be randomly assigned (1:1) to receive cryolipolysis, while the contralateral side will receive ATX-101. This study was a pilot study designed to determine feasibility of this procedure.
Primary Outcome
Subcutaneous fat measurement will be performed using an ultrasound.
Interventions
- DRUG ATX-101
- DEVICE CoolCurve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2020-06-08 |
| Phase | NA |
Why NCT03284034 stopped before completion
NCT03284034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which ATX-101 is the first listed.
NCT03284034 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03284034 about?
NCT03284034 is a clinical study titled "Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat". This is a prospective randomized controlled study comparing the efficacy of cryolipolysis versus ATX-101 (deoxycholic acid) for the treatment of upper back fat. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. The...
What is the current status of trial NCT03284034?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2017-11-27. Estimated completion is 2020-06-08.
What interventions are being tested in trial NCT03284034?
The interventions under investigation include: ATX-101 (DRUG), CoolCurve (DEVICE).
Who is sponsoring clinical trial NCT03284034?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03284034's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI